<DOC>
	<DOCNO>NCT00002515</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Bone marrow transplantation may allow doctor give high dos chemotherapy kill tumor cell . PURPOSE : Phase II trial study effectiveness combination chemotherapy thiotepa , carboplatin , topotecan follow bone marrow transplantation treat patient metastatic progressive rare cancer .</brief_summary>
	<brief_title>Combination Chemotherapy Followed Bone Marrow Transplantation Treating Patients With Rare Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Improve long term disease-free survival patient rare cancer high risk lethal relapse use myeloablative chemotherapy thiotepa , carboplatin , topotecan follow autologous bone marrow peripheral blood stem cell rescue . OUTLINE : Autologous bone marrow peripheral blood stem cell ( PBSC ) harvest . Patients receive high-dose thiotepa IV 3 hour day -8 -6 , carboplatin IV 4 hour day -5 -3 , topotecan IV 30 minute day -8 -4 . Autologous bone marrow PBSC reinfused day 0 . Patients receive filgrastim ( G-CSF ) IV twice daily begin day 1 . Patients follow 1 year . PROJECTED ACCRUAL : Approximately 50 patient accrue study within 5 year .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Neuroblastoma</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Liver Neoplasms</mesh_term>
	<mesh_term>Neoplasms , Germ Cell Embryonal</mesh_term>
	<mesh_term>Kidney Neoplasms</mesh_term>
	<mesh_term>Retinoblastoma</mesh_term>
	<mesh_term>Testicular Neoplasms</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Thiotepa</mesh_term>
	<mesh_term>Topotecan</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm malignancy one follow type : Wilms ' tumor Liver cancer Desmoplastic small round cell tumor Nasopharyngeal carcinoma Fibrosarcoma Disease metastasize cure rate great 25 % conventional treatment disease progress prior chemotherapy , surgically resectable , salvage rate nonmyeloablative therapy great 25 % require Maximal benefit conventional ( nonmyeloablative ) dose combination chemotherapy require prior entry , recommend patient receive minimum one following : 2 course highdose cyclophosphamide ( per protocol MSKCC90062 ) 2 course highdose ifosfamide/etoposide ( poorrisk sarcoma protocol MSKCC90071A ) 1 course highdose cyclophosphamide plus 1 course highdose ifosfamide/etoposide Within 3 week initiation protocol therapy , patient must : In CR good PR OR Tumor consider `` chemosensitive '' , i.e. , 50 % great decrease least 1 measurable tumor parameter attributable prior chemotherapy without evidence progressive disease parameter Ineligible IRBapproved myeloablative regimens No evidence current bone marrow involvement bone marrow aspiration ( x4 ) biopsy ( x2 ) PATIENT CHARACTERISTICS : Age : 21 Performance status : Not specify Hematopoietic : Not specify Hepatic : Bilirubin great 1.5 time upper limit normal ( ULN ) SGOT great 1.5 time ULN Alkaline phosphatase great 1.5 time ULN 5'Nucleotidase great 1.5 time ULN Renal : Creatinine normal Creatinine clearance least 60 mL/min Cardiovascular : CPK normal Echocardiogram ( RNCA ) normal EKG normal PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy See Disease Characteristics Endocrine therapy Not specify Radiotherapy Not specify Surgery See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>chondrosarcoma</keyword>
	<keyword>recurrent childhood rhabdomyosarcoma</keyword>
	<keyword>stage IV childhood liver cancer</keyword>
	<keyword>recurrent neuroblastoma</keyword>
	<keyword>recurrent childhood liver cancer</keyword>
	<keyword>recurrent Wilms tumor childhood kidney tumor</keyword>
	<keyword>stage IV Wilms tumor</keyword>
	<keyword>recurrent retinoblastoma</keyword>
	<keyword>stage IV childhood lymphoblastic lymphoma</keyword>
	<keyword>recurrent childhood lymphoblastic lymphoma</keyword>
	<keyword>recurrent osteosarcoma</keyword>
	<keyword>stage IV ovarian germ cell tumor</keyword>
	<keyword>recurrent malignant testicular germ cell tumor</keyword>
	<keyword>childhood germ cell tumor</keyword>
	<keyword>alveolar childhood rhabdomyosarcoma</keyword>
	<keyword>recurrent childhood soft tissue sarcoma</keyword>
	<keyword>recurrent ovarian germ cell tumor</keyword>
	<keyword>childhood fibrosarcoma</keyword>
	<keyword>extragonadal germ cell tumor</keyword>
	<keyword>childhood desmoplastic small round cell tumor</keyword>
	<keyword>recurrent childhood small noncleaved cell lymphoma</keyword>
	<keyword>stage IV childhood small noncleaved cell lymphoma</keyword>
	<keyword>recurrent childhood large cell lymphoma</keyword>
	<keyword>stage IV childhood large cell lymphoma</keyword>
	<keyword>recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor</keyword>
	<keyword>stage IV lymphoepithelioma nasopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma nasopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma nasopharynx</keyword>
	<keyword>recurrent lymphoepithelioma nasopharynx</keyword>
</DOC>